Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Shares Issued: 2023-2024

Historic Shares Issued for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to $76.4 million.

  • Camp4 Therapeutics' Shares Issued rose 104938.71% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.9 million, marking a year-over-year change of. This contributed to the annual value of $76.4 million for FY2024, which is 41171.89% up from last year.
  • As of FY2024, Camp4 Therapeutics' Shares Issued stood at $76.4 million, which was up 41,171.89% from $185,000 recorded in FY2023.
  • Camp4 Therapeutics' 5-year Shares Issued high stood at $76.4 million for FY2024, and its period low was $185,000 during FY2023.
  • Moreover, its 2-year median value for Shares Issued was $38.3 million (2023), whereas its average is $38.3 million.
  • Data for Camp4 Therapeutics' Shares Issued shows a peak YoY spiked of 41,171.89% (in 2024) over the last 5 years.
  • Camp4 Therapeutics' Shares Issued (Yearly) stood at $185,000 in 2023, then skyrocketed by 41,171.89% to $76.4 million in 2024.